Herbst Group LLC Acquires New Shares in GE HealthCare Technologies Inc. $GEHC

Herbst Group LLC acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 27,750 shares of the company’s stock, valued at approximately $2,276,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Dodge & Cox raised its position in shares of GE HealthCare Technologies by 42.1% during the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after purchasing an additional 6,982,441 shares during the period. Capital Research Global Investors lifted its holdings in shares of GE HealthCare Technologies by 25.0% during the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock valued at $1,875,400,000 after purchasing an additional 4,998,154 shares in the last quarter. Boston Partners acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at approximately $287,627,000. Holocene Advisors LP grew its position in shares of GE HealthCare Technologies by 178.5% in the 2nd quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock valued at $298,306,000 after purchasing an additional 2,581,522 shares during the period. Finally, Temasek Holdings Private Ltd bought a new stake in GE HealthCare Technologies during the 3rd quarter worth approximately $99,922,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Up 1.1%

NASDAQ:GEHC opened at $71.98 on Thursday. The company has a market cap of $32.84 billion, a P/E ratio of 15.79, a price-to-earnings-growth ratio of 1.57 and a beta of 1.17. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $89.77. The business has a 50 day moving average price of $77.31 and a two-hundred day moving average price of $78.13. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm’s revenue was up 7.1% compared to the same quarter last year. During the same period last year, the company earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is presently 3.07%.

Analysts Set New Price Targets

GEHC has been the topic of several research analyst reports. Bank of America raised their target price on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a report on Monday, January 5th. Barclays increased their price objective on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th. Morgan Stanley boosted their price objective on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 4th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $98.00 target price on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Finally, BTIG Research reiterated a “buy” rating and set a $91.00 target price on shares of GE HealthCare Technologies in a report on Thursday, March 19th. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Hold” and an average price target of $92.17.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.